Lancet:适度饮酒并不能降低心血管疾病风险!

2019-04-06 MedSci MedSci原创

squamous一直以来,很多研究表明适度摄入酒精,相比禁酒和大量饮酒,与心血管风险降低相关。东亚的研究可帮助明确这种相关性是否存在因果关系,因为两个常见的遗传突变可明显影响酒精的摄入模式。研究人员通过这两个突变评估心血管风险与基因型预测的平均酒精摄入在男性中的相关性,并与在女性中的发现进行对比。2004年6月25日-2008年7月15日,研究人员从中国的10个地区招募了512715位成年人,记录

一直以来,很多研究表明适度摄入酒精,相比禁酒和大量饮酒,与血管风险降低相关。东亚的研究可帮助明确这种相关性是否存在因果关系,因为两个常见的遗传突变可明显影响酒精的摄入模式。研究人员通过这两个突变评估血管风险与基因型预测的平均酒精摄入在男性中的相关性,并与在女性中的发现进行对比。

2004年6月25日-2008年7月15日,研究人员从中国的10个地区招募了512715位成年人,记录酒精摄入量和其他特征。随访10年(直到2017年1月1日),通过死亡登记和医院记录监测心血管疾病(包括缺血性中风、脑出血和心肌梗死)。对161498位受试者进行基因鉴定,鉴定两个可改变酒精代谢的突变(ALDH2-rs671和ADH1B-rs1229984)。

33%(69897/210205)的男性在大部分情况下会饮酒,而女性仅2%(6245/302510)。在男性受试者中,传统流行病学研究表明个人自报的饮酒量与缺血性中风(14930例)、脑出血(3496例)和心肌梗死(2958例)存在U形关联;自报每周酒精摄入100g(每天饮酒1-2次)的男性这三种疾病的发病风险均低于不饮酒或酗酒的人。与此相反,尽管基因型预测的平均男性酒精摄入量的范围很大(4-256g/周,0-4次/天),但与疾病风险无任何U形关联。基因型预测的酒精摄入与卒中风险存在连续的正性log线性关联,而且脑出血的相关性要强于缺血性卒中(1.58,95% CI 1.36-1.84,p<0.0001 vs 1.27,1.13-1.43,p=0.0001)。但基因型预测的酒精摄入与心肌梗死风险无相关性。此外,饮酒与收缩压存在强相关性(p<0.0001)。对于女性,饮酒与血压、卒中或心肌梗死无正性关联。

遗传流行病学显示,适度饮酒预防中风的保护作用在很大程度上是没有因果关系的。相反,饮酒可升高血压、增加中风的风险,而且,本研究结果还表明饮酒对心肌梗死的风险无明显影响。

原始出处:

Iona Y Millwood,et al. Conventional and genetic evidence on alcohol and vascular disease aetiology: a prospective study of 500 000 men and women in China.The Lancet. April 4,2019.https://doi.org/10.1016/S0140-6736(18)31772-0

本文系梅斯医学(MedSci)原创编译,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1830016, encodeId=8787183001696, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sat Oct 19 18:15:00 CST 2019, time=2019-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473166, encodeId=16bd14e316601, content=<a href='/topic/show?id=862be0746bc' target=_blank style='color:#2F92EE;'>#疾病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70746, encryptionId=862be0746bc, topicName=疾病风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c757221906, createdName=花花1368, createdTime=Mon Apr 08 06:15:00 CST 2019, time=2019-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498552, encodeId=b0be1498552de, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Mon Apr 08 06:15:00 CST 2019, time=2019-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364275, encodeId=58303642e539, content=了解一下,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Sun Apr 07 21:36:02 CST 2019, time=2019-04-07, status=1, ipAttribution=)]
    2019-10-19 howi
  2. [GetPortalCommentsPageByObjectIdResponse(id=1830016, encodeId=8787183001696, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sat Oct 19 18:15:00 CST 2019, time=2019-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473166, encodeId=16bd14e316601, content=<a href='/topic/show?id=862be0746bc' target=_blank style='color:#2F92EE;'>#疾病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70746, encryptionId=862be0746bc, topicName=疾病风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c757221906, createdName=花花1368, createdTime=Mon Apr 08 06:15:00 CST 2019, time=2019-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498552, encodeId=b0be1498552de, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Mon Apr 08 06:15:00 CST 2019, time=2019-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364275, encodeId=58303642e539, content=了解一下,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Sun Apr 07 21:36:02 CST 2019, time=2019-04-07, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1830016, encodeId=8787183001696, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sat Oct 19 18:15:00 CST 2019, time=2019-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473166, encodeId=16bd14e316601, content=<a href='/topic/show?id=862be0746bc' target=_blank style='color:#2F92EE;'>#疾病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70746, encryptionId=862be0746bc, topicName=疾病风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c757221906, createdName=花花1368, createdTime=Mon Apr 08 06:15:00 CST 2019, time=2019-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498552, encodeId=b0be1498552de, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Mon Apr 08 06:15:00 CST 2019, time=2019-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364275, encodeId=58303642e539, content=了解一下,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Sun Apr 07 21:36:02 CST 2019, time=2019-04-07, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1830016, encodeId=8787183001696, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sat Oct 19 18:15:00 CST 2019, time=2019-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473166, encodeId=16bd14e316601, content=<a href='/topic/show?id=862be0746bc' target=_blank style='color:#2F92EE;'>#疾病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70746, encryptionId=862be0746bc, topicName=疾病风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c757221906, createdName=花花1368, createdTime=Mon Apr 08 06:15:00 CST 2019, time=2019-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498552, encodeId=b0be1498552de, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Mon Apr 08 06:15:00 CST 2019, time=2019-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364275, encodeId=58303642e539, content=了解一下,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Sun Apr 07 21:36:02 CST 2019, time=2019-04-07, status=1, ipAttribution=)]
    2019-04-07 天地飞扬

    了解一下,谢谢分享!

    0

相关资讯

Osteoporos Int:饮酒是否增加髋部骨折风险 因年龄和性别而异

2018年7月,挪威学者发表在《Osteoporos Int》的NOREPOS研究表明,挪威队列中,酒精摄入和髋部骨折风险之间的相关性随着年龄和性别的不同而具有差异。

血检无异常的酒后腹痛,背后暗藏“杀机”!| Medscape病例分享

酒后腹痛,你首先会想到什么?很多临床医生会说:急性胰腺炎。没错,但是除此之外,还有很多其他罕见原因,比如下面这个饮酒引起的的腹痛案例,可以说是“暗藏玄机”!

Nature:饮酒和吸烟是食管癌的关键风险因子

根据本周《自然》在线发表的一篇论文,癌症突变会发生在生理学特征正常的食管细胞内,并会随着时间推移而积聚。包括饮酒和吸烟在内的风险因子会促使突变细胞数量增加,这证实了这些环境因子对于食管癌发展的重要影响。

19岁得肝硬化,无肝炎饮酒史,排除不明原因,手抖,是何病?

年纪轻轻从未得过肝炎,也滴酒不沾,检查结果也排除了病毒性肝炎及自身免疫性肝硬化,那到底是什么原因导致的肝硬化?医生下诊断为“不明原因肝硬化”,给予了保肝药物治疗,可半年后病情不见起色,反而在逐渐加重。如果你是主治医生,你该如何考虑?

Nature:烟、酒致癌又一实锤!科学家在亚洲人群中证实,吸烟、喝酒会大大加速正常食道细胞致癌突变的积累

2019年1月3日,日本京都大学的Seishi Ogawa团队针对更大规模人群的研究证实,随着年纪的增长,正常食管细胞会积累越来越多的癌症突变。一些带有癌症突变的正常细胞在很早的时候便开始形成克隆,推动癌症的发生。

警惕:除了头孢,服这7类药物饮酒也致死

上个月一同事感冒吃药后参加了一个饭局,喝了点酒,结果当晚半夜就感到身体极度不适,胸闷气短。被120送到医院抢救了一个晚上,终于从死神怀里把他拉了回来。说起此事,这个同事便后怕不已,自此以后彻底戒酒了。